Donetyle M 10 Tablet combines Donepezil 5mg and Memantine 10mg, offering a dual-action approach for patients with moderate to severe Alzheimer’s disease. Donepezil enhances cholinergic function, improving memory and cognition, while Memantine regulates glutamate activity to reduce neurotoxicity and slow disease progression.
Belonging to the neurology and CNS segment, this combination is widely prescribed for patients who require both symptomatic relief and cognitive protection. It addresses memory loss, confusion, behavioral disturbances, and cognitive decline, providing comprehensive Alzheimer’s management.
Donetyle M 10 is essential in long-term Alzheimer’s care, making it a high-demand product in hospitals, neurology clinics, and geriatric care centers. Its dual mechanism ensures better clinical outcomes and patient adherence.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Donetyle M 10 Tablet represents a profitable B2B opportunity in the CNS and Alzheimer’s treatment segment, with strong and recurring demand across India.